Cargando…
Epidermal Growth Factor Receptor and Ki-67 as Predictive Biomarkers Identify Patients Who Will Be More Sensitive to Intravesical Instillations for the Prevention of Bladder Cancer Recurrence after Radical Nephroureterectomy
BACKGROUND: To date, prophylactic intravesical chemotherapy after radical nephroureterectomy is one of the few available treatments that effectively prevent secondary bladder cancer. However, treating all patients with prophylactic intravesical chemotherapy is excessive for patients who are at a low...
Autores principales: | Long, Xingbo, Zu, Xiongbing, Li, Yuan, He, Wei, Hu, Xiheng, Tong, Shiyu, Wang, Zhi, Chen, Minfeng, Qi, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117727/ https://www.ncbi.nlm.nih.gov/pubmed/27870887 http://dx.doi.org/10.1371/journal.pone.0166884 |
Ejemplares similares
-
Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy
por: Moriarty, Michael A., et al.
Publicado: (2015) -
Intraoperative Mitomycin C Bladder Instillation During Radical Nephroureterectomy Is Feasible and Safe
por: Nadler, Naomi, et al.
Publicado: (2021) -
Assessment of Therapeutic Benefit and Option Strategy on Intravesical Instillation for Preventing Bladder Cancer Recurrence after Radical Nephroureterectomy in Patients with Upper Urinary Tract Urothelial Carcinoma
por: Fan, Bo, et al.
Publicado: (2022) -
miR-150 Modulates Cisplatin Chemosensitivity and Invasiveness of Muscle-Invasive Bladder Cancer Cells via Targeting PDCD4 In Vitro
por: Lei, Ye, et al.
Publicado: (2014) -
High frequency of bladder cancer after nephroureterectomy: justification for adjuvant intravesical treatment?
por: Mekayten, Matan, et al.
Publicado: (2018)